Jump to main content.


EDSP Chronology

The following graphic depicts the Endocrine Disruptor Screening Program (EDSP) chronology. Click on any of the events to view a brief description of each.
Endocrine Disruptor Screening Program Chronology image map

Program Timeline. Link to 12/02: FR Notice - Proposed Chemical Selection Approach for Initial Round of Screening Program Timeline. Link to 5/02: EDMVS Progress Report to Congress Program Timeline. Link to 8/96: FQPA and SDWA Program Timeline. Link to 10/96: EDSTAC Convenes Program Timeline. Link to 8/98: EDSP FR Notice Program Timeline. Link to 12/98: EDSP Policy FR Notice Program Timeline. Link to 12/99: NRDC Settlement Agreement Program Timeline. 8/00: EDSP Progress Report to Congress Program Timeline. Link to 10/01: EDMVS/FACA Convenes Program Timeline. Link to 06/04: EDMVAC Established Program Timeline. Link to 09/05: FR Notice - Chemical Selection Approach for Initial Round of Screening Program Timeline. Link to 7/99: SAB/SAP Review of EDSP

You will need the free Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more. If you need help accessing these PDF documents, please contact William Wooge at 202-564-8476 or wooge.william@epa.gov for assistance.

August 1996: Statutory Authorities
In August 1996, Congress passed both the Food Quality Protection Act (FQPA) [PDF, 50pp., 253KB, About PDF] and amendments to the Safe Drinking Water Act (SDWA), both containing provisions calling for the screening and testing of chemicals and pesticides for possible endocrine disrupting effects. These laws required EPA to develop a screening program that uses appropriate validated test systems and other scientifically relevant information to determine if the effect that certain substances have in humans is similar to the effect produced by a naturally occurring hormone.

The Food Quality Protection Act amends the Federal Food, Drug, and Cosmetic Act. Read more about the Federal Food, Drug, and Cosmetic Act Amendments.Exit Disclaimer

1996: EDSTAC Convenes
The Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), a federal advisory committee, was formed in 1996 to make recommendations on how to develop the screening and testing program called for by Congress. Representatives from industry, government, environmental and public health groups, worker safety groups, and academia comprised EDSTAC. The members of EDSTAC were tasked with developing consensus-based recommendations for a screening program that would provide EPA with the information needed to make regulatory decisions about chemicals that disrupt the endocrine system.

EDSTAC thoroughly reviewed and discussed the scientific information available about endocrine disruptors and sought the opinion of other experts and members of the public during its 2-years of deliberations. EDSTAC presented its final report to EPA in September 1998. Read more about the creation of EDSTAC out of date and it's participants.

August 1998: Federal Register Notice - EDSP
EPA outlined the Endocrine Disruptor Screening Program (EDSP), which incorporated many of EDSTAC's recommendations, in an August 1998 Federal Register Notice [PDF, 4pp., 34KB, About PDF]. This notice provides operational details regarding the major elements of EPA's Endocrine Disruptor Screening Program.

December 1998: Federal Register Notice - Proposed Statement of Policy
EPA provided additional details on the Endocrine Disruptor Screening Program (EDSP), including the major elements of the Program and its implementation, in a December 1998 Federal Register Notice [PDF, 28pp., 228KB, About PDF].

July 1999: Federal Register Notice - Proposed Statement of Policy
At the request of EPA, a joint subcommittee of the EPA Science Advisory Board (SAB) and the FIFRA
Scientific Advisory Panel (SAP) reviewed a set of scientific issues related to the development of the
Agency’s EDSP. The results of the review are summarized in the 1999 SAB/SAP Report: Review of the EPA's Proposed Environmental Endocrine Disruptor Screening Program [PDF, 48pp., 1MB, About PDF].

1999: NRDC Settlement Agreement
EPA and the Natural Resources Defense Council (NRDC) entered into an agreement to settle part of a lawsuit that NRDC filed against EPA regarding implementation of the Endocrine Disruptor Screening Program (EDSP). In the settlement agreement, EPA agreed, among other things, to use best efforts to complete validation of certain screening and testing methodologies that are proposed for use in the program by specific dates, and to use best efforts to start requiring screening and testing of certain chemicals by specific dates.

Read the Signed NRDC Settlement Agreement [PDF, 16pp., 873KB, About PDF]

2000: Report to Congress - EDSP Implementation Progress
EPA presented a Report to Congress in August 2000 [PDF, 20pp., 88KB, About PDF] summarizing endocrine disruptor issues and describing the Endocrine Disruptor Screening Program (EDSP). EPA also described its progress in implementing the program, ongoing studies relating to endocrine disruptors, and the measures being taken to address animal welfare concerns under the EDSP.

2001: EDMVS Formed
The Endocrine Disruptor Methods Validation Subcommittee (EDMVS) was established under the EPA's National Advisory Council for Environmental Policy and Technology (in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2 Section 9c)). EDMVS provides technical advice and counsel to EPA on scientific issues associated with the validation of Tier 1 and Tier 2 assays on topics including the development and choice of initial protocols; prevalidation study designs; and validation study designs. All of the study results generated during protocol development, prevalidation and validation will be combined into EDSP method-specific documents suitable for external peer review. External scientific peer review of the EDSP methods will be arranged by EPA through an Agency-approved external scientific peer review panel (63 FR 71542).

Read the EDMVS Mission Statement [PDF, 2pp., 8KB, About PDF]

2002: Report to Congress - EDMVS Progress
EPA provided an update on the progress of EDMVS [PDF, 6pp., 19KB, About PDF] and described validation processes that incorporated the advice of the EDMVS. It also summarized recent subcommittee meetings and presented a list of subcommittee members. Read Attachment A to the report [PDF, 9pp., 24KB, About PDF].

December 2002: Federal Register Notice - Proposed Chemical Selection Approach for Initial Screening
EPA set forth for public comment the Proposed Chemical Selection Approach for Initial Screening [PDF, 19pp., 119KB, About PDF] which presents the approach EPA intends to use for selecting 50 to 100 chemicals for initial screening under the Federal Food, Drug and Cosmetic Act.

June 2004: EDMVAC Established
The Endocrine Disruptor Methods Validation Advisory Committee (EDMVAC) was established in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2 Section 9c)) and was formed to replace EDMVS. The EDMVAC will continue to function like EDMVS by providing advice and recommendations to EPA on scientific and technical aspects of the Tier I screens and Tier II assays being considered for the Endocrine Disruptor Screening Program. The committee will evaluate relevant scientific issues, protocols, data, and interpretations of the data for the assays during the validation process. EDMVAC will also provide advice on the composition of the Tier I screening battery.

Read the EDMVAC Charter [PDF, 3pp., 20KB, About PDF]

September 2005: Federal Register Notice - Chemical Selection Approach for Initial Screening
EPA published the Chemical Selection Approach for Initial Screening [PDF, 17pp., 125KB, About PDF] which presents the approach EPA intends to use for selecting 50 to 100 chemicals for initial screening under the Federal Food, Drug and Cosmetic Act.

June 2007: Federal Register Notice - Draft List of Chemicals for Initial Screening
EPA published the Draft List of Initial Pesticide Active Ingredients and Pesticide Inerts to be Considered for Screening under the Federal Food, Drug and Cosmetic Act [PDF, 18pp., 131KB, About PDF].

December 2007: Federal Register Notice - Draft Policies and Procedures
EPA has issued two Federal Register (FR) notices seeking public comment on the Endocrine Disruptor Screening Program:

Top of page


 

You will need the free Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more. If you need help accessing these PDF documents, please contact William Wooge at 202-564-8476 or wooge.william@epa.gov for assistance.


Local Navigation


Jump to main content.